Literature DB >> 8377842

Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes.

G J Molderings1, D Moura, K Fink, H Bönisch, M Göthert.   

Abstract

Imidazolines bind with high affinity not only to alpha-adrenoceptors but also to specific imidazoline binding sites (IBS) labelled by either [3H]clonidine or [3H]idazoxan and termed I1- and I2-IBS, respectively. Since bovine adrenal chromaffin cells lack alpha 2-adrenoceptors, we investigated the pharmacological characteristics of [3H]clonidine binding sites in the bovine adrenal medulla. The binding of [3H]clonidine was rapid, reversible, partly specific (as defined by naphazoline 0.1 mmol/l; 55% specific binding at [3H]clonidine 10 nmol/l), saturable and of high affinity. The specific binding of [3H]clonidine to bovine adrenal medullary membranes was concentration-dependently inhibited by various imidazolines, guanidines and an oxazoline derivative but not, or with negligible affinity, by rauwolscine and (-)-adrenaline. In most cases, the competition curves were best fitted to a two-site model. The rank order of affinity for the high affinity site (in a few cases the single detectable site) was as follows: naphazoline > or = BDF 7579 (4-chloro-2-isoindolinyl guanidine) > or = clonidine > or = cirazoline > or = BDF 6143 (4-chloro-2-(2-imidazoline-2-ylamino)-isoindoline hydrochloride) > BDF 7572 (4,7-chloro-2-(2-imidazolin-2-ylamino)-isoindoline) > moxonidine = rilmenidine > BDF 6100 (2-(2-imidazoline-2-ylamino)-isoindoline) = idazoxan > phentolamine > aganodine = guanabenz > amiloride > histamine. This rank order is compatible with the pharmacological properties of the I1-IBS. The non-hydrolysable GTP-analogue Gpp(NH)p (5'guanylylimidodiphosphate; 100 mumol/l) inhibited specific [3H]clonidine binding by about 50%. Equilibrium [3H]clonidine binding was also significantly reduced by K+ and Mg2+.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8377842     DOI: 10.1007/bf00168539

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  46 in total

1.  Characterization of the [3H]-desipramine binding site of the bovine adrenomedullary plasma membrane.

Authors:  J Michael-Hepp; B Blum; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

2.  Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney.

Authors:  V Lachaud-Pettiti; R A Podevin; Y Chrétien; A Parini
Journal:  Eur J Pharmacol       Date:  1991-01-25       Impact factor: 4.432

3.  Effects of clonidine and other imidazole-receptor binding agents on second messenger systems and calcium influx in bovine adrenal chromaffin cells.

Authors:  S Regunathan; M J Evinger; M P Meeley; D J Reis
Journal:  Biochem Pharmacol       Date:  1991-10-24       Impact factor: 5.858

4.  Pharmacological characterization of the imidazoline receptor which mediates inhibition of noradrenaline release in the rabbit pulmonary artery.

Authors:  G J Molderings; F Hentrich; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-12       Impact factor: 3.000

5.  Non-adrenergic binding sites for the "alpha 2-antagonist" [3H]idazoxan in the rabbit urethral smooth muscle. Pharmacological and biochemical characterization.

Authors:  F Yablonsky; J P Dausse
Journal:  Biochem Pharmacol       Date:  1991-03-01       Impact factor: 5.858

6.  Possible muscarinic regulation of catecholamine secretion mediated by cyclic GMP in isolated bovine adrenal chromaffin cells.

Authors:  G Derome; R Tseng; P Mercier; I Lemaire; S Lemaire
Journal:  Biochem Pharmacol       Date:  1981-04-15       Impact factor: 5.858

7.  [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.

Authors:  M C Michel; O E Brodde; B Schnepel; J Behrendt; R Tschada; H J Motulsky; P A Insel
Journal:  Mol Pharmacol       Date:  1989-03       Impact factor: 4.436

8.  Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area.

Authors:  R E Gomez; P Ernsberger; G Feinland; D J Reis
Journal:  Eur J Pharmacol       Date:  1991-03-26       Impact factor: 4.432

9.  Nonadrenergic modulation by clonidine of the cosecretion of catecholamines and enkephalins in adrenal chromaffin cells.

Authors:  T T Nguyen; A De Léan
Journal:  Can J Physiol Pharmacol       Date:  1987-05       Impact factor: 2.273

10.  Evidence for a bioactive clonidine-displacing substance in peripheral tissues and serum.

Authors:  M P Meeley; M L Hensley; P Ernsberger; D Felsen; D J Reis
Journal:  Biochem Pharmacol       Date:  1992-08-18       Impact factor: 5.858

View more
  21 in total

Review 1.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.

Authors:  W Raasch; U Schäfer; J Chun; P Dominiak
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Respective contributions of alpha-adrenergic and non-adrenergic mechanisms in the hypotensive effect of imidazoline-like drugs.

Authors:  V Bruban; J Feldman; H Greney; M Dontenwill; S Schann; C Jarry; M Payard; J Boutin; E Scalbert; B Pfeiffer; P Renard; P Vanhoutte; P Bousquet
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

Review 3.  The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.

Authors:  P Ernsberger; J E Friedman; R J Koletsky
Journal:  J Hypertens Suppl       Date:  1997-01

4.  Hyperadrenergic state following acute withdrawal from clonidine used at supratherapeutic doses.

Authors:  N J Sarlis; O Caticha; J L Anderson; C Kablitz; F S Shihab
Journal:  Clin Auton Res       Date:  1996-04       Impact factor: 4.435

5.  No evidence for functional imidazoline receptors on locus coeruleus neurons.

Authors:  B Szabo; R Fröhlich; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

6.  The stimulatory effect of clonidine through imidazoline receptors on locus coeruleus noradrenergic neurones is mediated by excitatory amino acids and modulated by serotonin.

Authors:  J A Ruiz-Ortega; L Ugedo; J Pineda; J A García-Sevilla
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

7.  The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain.

Authors:  G Olmos; R Alemany; P V Escriba; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

8.  Inhibitory presynaptic imidazoline receptors on sympathetic nerves in the rabbit aorta differ from I1- and I2-imidazoline binding sites.

Authors:  G J Molderings; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

9.  Characterization of non-adrenergic [3H]clonidine binding sites in rat stomach: high affinity of imidazolines, guanidines and sigma ligands.

Authors:  G J Molderings; K Donecker; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

10.  Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.

Authors:  R G Evans; W P Anderson
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.